To ask the Secretary of State for Health and Social Care, pursuant to his Oral Answer of 20 March 2018, Official Report, column 156, on motor neurone disease, which projects received that £52 million investment; and which 24 clinical trials are being recruited to.
19 April 2018
In 2016-17, the National Institute for Health Research (NIHR) invested £52.2 million into health research covered by the ‘Neurological conditions’ category of the UK Health Research Classification System. This £52.2 million was used to fund and support a range of research studies and research infrastructure for neurological conditions and within that, £4.58 million was spent specifically on Motor Neurone Disease (MND) and closely-related conditions.
The NIHR provides the support, expertise and facilities that the NHS needs to undertake world-leading research funded by the NIHR, and other public, charity and life sciences industry partners, by funding a range of infrastructure facilities.
The NIHR Clinical Research Network is currently supporting 19 non-commercial studies and clinical trials on MND and closely-related conditions which are open and recruiting participants. The non-commercial studies are listed in the table below. There are currently two commercial studies which are also recruiting participants.
In 2016-17, the NIHR Research Infrastructure supported 23 studies and trials on MND and closely-related conditions in the NIHR Biomedical Research Centres, Units and other research infrastructure. The majority of these studies have been funded by research charities including the Motor Neurone Disease Association, other research funders and the life sciences industry.
NIHR Clinical Research Network supported Non-Commercial studies on MND and closely-related conditions which are open and recruiting participants
CPMS Study ID
Study Short Name
Trajectories of Outcome in Neurological Conditions Phase 3 Consent and questionnaire
Trajectories of Outcome in Neurological Conditions Phase 2 Demographics and Clinical Info
Motor System Genomics, version 1.0
ALS Biomarkers Study
Tonic 2 Phase 4
MND Register for England, Wales and Northern Ireland
Trajectories of Outcome in Neurological Conditions Phase 1
CSF collection in patients with neurodegenerative diseases
BioMOx Phase 2: The Oxford Study for Biomarkers in Motor Neuron Disease
A Multicentre Biomarker Study in Neurodegeneration
Contributing clinical MRI scans to multi-centre collaboration
Using MRI to investigate energy metabolism in MND
Improving support for family and friends caring for people with MND
Serial fasciculation measurements in motor neurone disease
Care Augmentation by Location-linked messaging CALL-Me
MIROCALS_H2020/PHRC-N/2014/GB-01_ID-IL-2_Neuro-Inflammation in ALS Pts
Change in MND